PMID: 15229068Jul 2, 2004Paper

Medical decision making in antipsychotic drug choice for schizophrenia

The American Journal of Psychiatry
Johannes HamannWerner Kissling

Abstract

The influence of patient and physician variables on antipsychotic drug choice for patients with schizophrenia was assessed. Interviews with 100 psychiatrists on drug choice for 200 patients suffering from schizophrenia were conducted. Data were analyzed by using multiple logistic regression. Older physicians were up to five times more likely to prescribe first-generation antipsychotics. Patient variables did not influence treatment decisions significantly. There is an urgent need for more research on clinical decision making and quality management.

Citations

Oct 19, 2006·JAMA : the Journal of the American Medical Association·Paul J HauptmanThomas E Burroughs
Oct 20, 2005·European Journal of Clinical Pharmacology·Johannes HamannWerner Kissling
Oct 25, 2007·Administration and Policy in Mental Health·Michael Joseph Sernyak, Robert Rosenheck
Mar 4, 2008·Implementation Science : IS·Paul R FalzerD Melissa Garman
Apr 3, 2012·BMC Psychiatry·Sameer JauharUNKNOWN European Federation of Psychiatric Trainees' Research Group
Jan 1, 2005·International Journal of Psychiatry in Clinical Practice·Eromona Whiskey, David Taylor
Feb 9, 2010·Expert Review of Neurotherapeutics·Ludovic SamalinPierre-Michel Llorca
Jul 1, 2010·Expert Opinion on Pharmacotherapy·Ofer AgidGary Remington
Jan 5, 2011·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Carmen R Green, Tamera Hart-Johnson
Feb 13, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Paola RoccaFilippo Bogetto
Dec 5, 2008·Journal of Pain and Symptom Management·Carmen R GreenTamera A Hart-Johnson
Mar 3, 2009·L'Encéphale·A CharpentierP Thomas
Jun 24, 2005·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Cathryn A Galanter, Vimla L Patel
Oct 24, 2007·Acta Psychiatrica Scandinavica. Supplementum·S LevanderE Lindström
Nov 27, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·E Cabrina CampbellStanley N Caroff
Jul 28, 2016·Journal of Managed Care & Specialty Pharmacy·Sujith RamachandranAmit S Patel
Jan 29, 2016·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Sangeeta DeyGraham Mellsop
Nov 30, 2016·Journal of Medical Ethics·Stijn CleymansChris Bervoets
Apr 1, 2011·The Journal of Nervous and Mental Disease·Ludovic SamalinPierre-Michel Llorca
Apr 1, 2020·Irish Journal of Psychological Medicine·R RowntreeL Feeney
Jul 15, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Debbie Schachter, Irwin Kleinman
Jan 8, 2021·Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·Benjamin David WilliamsAdam Joiner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here